These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 213182)

  • 21. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period.
    Bronne-Shanbury C; Miller D; Standfast AF
    J Hyg (Lond); 1976 Apr; 76(2):265-75. PubMed ID: 177703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acellular pertussis vaccine].
    Wiedermann G; Ambrosch F; Vanura H
    Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?
    Edwards KM
    Clin Infect Dis; 2001 Jun; 32(12):1698-9. PubMed ID: 11360209
    [No Abstract]   [Full Text] [Related]  

  • 27. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of the serotypes of strains of Bordetella pertussis isolated between 1952 and 1971 in Rumania].
    Andreescu V; Caffé I; Marion M
    Arch Roum Pathol Exp Microbiol; 1974 Mar; 33(1):17-22. PubMed ID: 4363932
    [No Abstract]   [Full Text] [Related]  

  • 29. THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES.
    CHALVARDJIAN N
    Can Med Assoc J; 1965 May; 92(21):1114-6. PubMed ID: 14285295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.
    Tsang RS; Lau AK; Sill ML; Halperin SA; Van Caeseele P; Jamieson F; Martin IE
    J Clin Microbiol; 2004 Nov; 42(11):5364-7. PubMed ID: 15528744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Bordetella pertussis strains of recent isolation.
    Stefanelli P; De Marzi L; Robino L; Roman D; Basso F; D'Orazio P; Di Tommaso S; Vasile E; Caciolo E; Spigaglia P; Mastrantonio P
    New Microbiol; 1999 Jul; 22(3):187-94. PubMed ID: 10423736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comments on the immunizing capicity of B. pertussin serotypes.
    Andreescu V; Caffé I; Marion M; Ivan I
    Arch Roum Pathol Exp Microbiol; 1977; 36(2):107-14. PubMed ID: 209764
    [No Abstract]   [Full Text] [Related]  

  • 33. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.
    Borisova O; Kombarova SY; Zakharova NS; van Gent M; Aleshkin VA; Mazurova I; Mooi FR
    Clin Vaccine Immunol; 2007 Mar; 14(3):234-8. PubMed ID: 17202309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Bordetella type III secretion system: its application to vaccine development.
    Abe A; Nagamatsu K; Watanabe M
    Microbiol Immunol; 2008 Feb; 52(2):128-33. PubMed ID: 18380810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B. pertussis in Czechoslovakia in the years 1966-1970.
    Maixnerová M; Burianová-Vysoká B; Stránský V
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):267-72. PubMed ID: 4342922
    [No Abstract]   [Full Text] [Related]  

  • 39. Mouse or man? Which are pertussis vaccines to protect?
    Preston NW; Stanbridge TN
    J Hyg (Lond); 1976 Apr; 76(2):249-56. PubMed ID: 177701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of pertussis vaccines: a brighter horizon.
    Preston NW; Stanbridge TN
    Br Med J; 1972 Aug; 3(5824):448-51. PubMed ID: 4341645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.